Journal article icon

Journal article

Meningococcal vaccines.

Abstract:

The successful introduction of a protein-polysaccharide conjugate vaccine against serogroup C meningococci into the UK infant immunization schedule, in combination with a catch-up campaign for individuals less than 18 years of age, has seen virtually all group C disease eliminated in childhood. From being a devastating disease with a very high mortality, the possibility of eradicating invasive meningococcal disease now seems eminently feasible. Since similar technology is likely to facilitate...

Expand abstract

Actions


Access Document


Publisher copy:
10.1586/14760584.1.1.75

Authors


More by this author
Institution:
University of Oxford
Division:
MPLS
Department:
Engineering Science
Sub department:
Institute of Biomedical Engineering
Role:
Author
Journal:
Expert review of vaccines More from this journal
Volume:
1
Issue:
1
Pages:
75-84
Publication date:
2002-06-01
DOI:
EISSN:
1744-8395
ISSN:
1476-0584
Language:
English
Keywords:
Pubs id:
pubs:119422
UUID:
uuid:a95ba24f-ae35-4503-96c5-b47414969fb6
Local pid:
pubs:119422
Source identifiers:
119422
Deposit date:
2012-12-19

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP